Tan H - Search Results

1

Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin.

Tan H, Yang S, Liu C, Cao J, Mu G, Wang F. Tan H, et al. Biomed Pharmacother. 2012 Dec;66(8):648-54. doi: 10.1016/j.biopha.2011.04.007. Epub 2011 Jun 12. Biomed Pharmacother. 2012. PMID: 23122594

2

Characterization and secondary structure analysis of endostatin covalently modified by polyethylene glycol and low molecular weight heparin.

Tan H, Yang S, Feng Y, Liu C, Cao J, Mu G, Wang F. Tan H, et al. J Biochem. 2008 Aug;144(2):207-13. doi: 10.1093/jb/mvn060. Epub 2008 May 7. J Biochem. 2008. PMID: 18463113

3

Research advances of endostatin and its short internal fragments.

Xu HL, Tan HN, Wang FS, Tang W. Xu HL, et al. Curr Protein Pept Sci. 2008 Jun;9(3):275-83. doi: 10.2174/138920308784534050. Curr Protein Pept Sci. 2008. PMID: 18537682 Review.

4

The preventive effects of heparin-superoxide dismutase on carbon tetrachloride-induced acute liver failure and hepatic fibrosis in mice.

Liu J, Tan H, Sun Y, Zhou S, Cao J, Wang F. Liu J, et al. Among authors: tan h. Mol Cell Biochem. 2009 Jul;327(1-2):219-28. doi: 10.1007/s11010-009-0060-2. Epub 2009 Feb 26. Mol Cell Biochem. 2009. PMID: 19242656

5

Pharmacokinetic analysis of in vivo disposition of heparin-superoxide dismutase.

Liu J, Zhao T, Tan H, Cheng Y, Cao J, Wang F. Liu J, et al. Among authors: tan h. Biomed Pharmacother. 2010 Dec;64(10):686-91. doi: 10.1016/j.biopha.2010.09.008. Epub 2010 Sep 25. Biomed Pharmacother. 2010. PMID: 20970950

6

Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor make low molecular weight heparin-endostatin and polyethylene glycol-endostatin potential candidates for anti-angiogenesis drug.

Tan H, Mu G, Zhu W, Liu J, Wang F. Tan H, et al. Biol Pharm Bull. 2011;34(4):545-50. doi: 10.1248/bpb.34.545. Biol Pharm Bull. 2011. PMID: 21467643 Free article.

7

Preparation of chitosan-based nanoparticles for delivery of low molecular weight heparin.

Wang J, Tan H, Yu A, Ling P, Lou H, Zhai G, Wu J. Wang J, et al. Among authors: tan h. J Biomed Nanotechnol. 2011 Oct;7(5):696-703. doi: 10.1166/jbn.2011.1326. J Biomed Nanotechnol. 2011. PMID: 22195488

8

Site-specific chemical modification of human serum albumin with polyethylene glycol prolongs half-life and improves intravascular retention in mice.

Zhao T, Cheng YN, Tan HN, Liu JF, Xu HL, Pang GL, Wang FS. Zhao T, et al. Biol Pharm Bull. 2012;35(3):280-8. doi: 10.1248/bpb.35.280. Biol Pharm Bull. 2012. PMID: 22382312 Free article.

9

N-terminal PEGylation of human serum albumin and investigation of its pharmacokinetics and pulmonary microvascular retention.

Zhao T, Yang Y, Zong A, Tan H, Song X, Meng S, Song C, Pang G, Wang F. Zhao T, et al. Among authors: tan h. Biosci Trends. 2012 Apr;6(2):81-8. Biosci Trends. 2012. PMID: 22621990 Free article.

10

Hematopoietic effects and mechanisms of Fufang e׳jiao jiang on radiotherapy and chemotherapy-induced myelosuppressed mice.

Liu M, Tan H, Zhang X, Liu Z, Cheng Y, Wang D, Wang F. Liu M, et al. Among authors: tan h. J Ethnopharmacol. 2014 Mar 28;152(3):575-84. doi: 10.1016/j.jep.2014.02.012. Epub 2014 Feb 15. J Ethnopharmacol. 2014. PMID: 24534527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,554 results

Search Page

Filters